1. Home
  2. CRMD vs WLDN Comparison

CRMD vs WLDN Comparison

Compare CRMD & WLDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRMD
  • WLDN
  • Stock Information
  • Founded
  • CRMD 2006
  • WLDN 1964
  • Country
  • CRMD United States
  • WLDN United States
  • Employees
  • CRMD N/A
  • WLDN N/A
  • Industry
  • CRMD Biotechnology: Pharmaceutical Preparations
  • WLDN Military/Government/Technical
  • Sector
  • CRMD Health Care
  • WLDN Consumer Discretionary
  • Exchange
  • CRMD Nasdaq
  • WLDN Nasdaq
  • Market Cap
  • CRMD 877.5M
  • WLDN 826.2M
  • IPO Year
  • CRMD 2010
  • WLDN 2006
  • Fundamental
  • Price
  • CRMD $11.28
  • WLDN $73.92
  • Analyst Decision
  • CRMD Strong Buy
  • WLDN Strong Buy
  • Analyst Count
  • CRMD 7
  • WLDN 2
  • Target Price
  • CRMD $17.33
  • WLDN $49.00
  • AVG Volume (30 Days)
  • CRMD 2.2M
  • WLDN 319.8K
  • Earning Date
  • CRMD 08-13-2025
  • WLDN 08-07-2025
  • Dividend Yield
  • CRMD N/A
  • WLDN N/A
  • EPS Growth
  • CRMD N/A
  • WLDN 79.39
  • EPS
  • CRMD 0.28
  • WLDN 1.68
  • Revenue
  • CRMD $82,553,827.00
  • WLDN $595,695,000.00
  • Revenue This Year
  • CRMD $238.38
  • WLDN N/A
  • Revenue Next Year
  • CRMD $53.52
  • WLDN $9.94
  • P/E Ratio
  • CRMD $40.46
  • WLDN $43.88
  • Revenue Growth
  • CRMD N/A
  • WLDN 12.40
  • 52 Week Low
  • CRMD $3.61
  • WLDN $30.43
  • 52 Week High
  • CRMD $17.43
  • WLDN $75.50
  • Technical
  • Relative Strength Index (RSI)
  • CRMD 39.54
  • WLDN 86.21
  • Support Level
  • CRMD $11.13
  • WLDN $69.36
  • Resistance Level
  • CRMD $11.86
  • WLDN $75.50
  • Average True Range (ATR)
  • CRMD 0.65
  • WLDN 2.84
  • MACD
  • CRMD -0.34
  • WLDN 0.71
  • Stochastic Oscillator
  • CRMD 3.81
  • WLDN 91.24

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

About WLDN Willdan Group Inc.

Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.

Share on Social Networks: